Related references
Note: Only part of the references are listed.Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells
Shixing Wu et al.
PLOS ONE (2013)
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
Mingqian Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication
Yi Shen et al.
JOURNAL OF NEUROSCIENCE (2012)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
Cancer Prevention With Natural Compounds
Norleena P. Collett et al.
SEMINARS IN ONCOLOGY (2010)
Natural products and drug discovery Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?
Hong-Fang Ji et al.
EMBO REPORTS (2009)
Perspectives for Cancer Prevention With Natural Compounds
A. R. M. Ruhul Amin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome
Ryo Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Cancer preventive properties of ginger: A brief review
Yogeshwer Shukla et al.
FOOD AND CHEMICAL TOXICOLOGY (2007)
Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China
W. Xu et al.
EUROPEAN JOURNAL OF CANCER CARE (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus
WL Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage
CP Rubbi et al.
EMBO JOURNAL (2003)
The p53-Mdm2 module and the ubiquitin system
D Michael et al.
SEMINARS IN CANCER BIOLOGY (2003)
Review article: herbal treatment in gastrointestinal and liver disease - benefits and dangers
L Langmead et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)